Calcium-dependent mechanisms of the reinstatement of nicotine-conditioned place preference by drug priming in rats.

Pharmacology, Biochemistry, and Behavior
Grazyna Biala, Barbara Budzynska

Abstract

Reinstatement of drug-seeking behaviour in animals is relevant to relapse to drug taking in humans. We used the conditioned place preference version of the reinstatement model to investigate the establishment, extinction, reinstatement and cross-reinstatement of nicotine-induced place conditioning in rats. Nicotine produced a place preference to the compartment paired with its injections during conditioning (0.5 mg/kg, i.p., three drug sessions). Once established, nicotine place preference was extinguished by repeated training. Following this extinction phase, nicotine-experienced rats were challenged with nicotine (0.5 mg/kg, i.p.), a cannabinoid receptor agonist WIN55,212-2 (0.5 mg/kg, i.p.), ethanol (0.5 g/kg, i.p.) or d-amphetamine (2 mg/kg, i.p.). The priming injections of nicotine, WIN55,212-2 and ethanol, but not of d-amphetamine renewed a preference for the compartment previously paired with nicotine. Finally, we examined the influence of the calcium channel antagonists, nimodipine (5 and 10 mg/kg, i.p.) and flunarizine (5 and 10 mg/kg, i.p.), on the reinstatement of nicotine place conditioning induced by WIN55,212-2 and ethanol. It was shown that the calcium channel blockers attenuated the reinstatement of nicotine-con...Continue Reading

References

Jan 1, 1992·Psychopharmacology·O Pucilowski
Jan 1, 1992·Psychopharmacology·W M ChornockS Leischow
Apr 1, 1992·Pharmacology, Biochemistry, and Behavior·M D Schechter, S M Meehan
Jan 1, 1991·Life Sciences·R KarlerL D Calder
Aug 1, 1990·The International Journal of the Addictions·J BrighamM L Stitzer
May 1, 1990·Alcohol·S W LeslieJ S Sims
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G Di Chiara, A Imperato
Dec 16, 1982·Brain Research·C SpyrakiA G Phillips
Jun 1, 1995·Pharmacology, Biochemistry, and Behavior·F O Risinger, R A Oakes
Sep 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·D J Calcagnetti, M D Schechter
Aug 10, 1993·European Journal of Pharmacology·O PucilowskiD S Janowsky
Jan 1, 1993·Annual Review of Pharmacology and Toxicology·L S SeidenG A Ricaurte
Sep 1, 1996·Psychopharmacology·C ChiamuleraM Tessari
Sep 1, 1996·Alcoholism, Clinical and Experimental Research·A C CollinsA E Bullock
Feb 1, 1997·Trends in Neurosciences·S Wonnacott
Dec 24, 1997·Brain Research. Brain Research Reviews·R C Pierce, P W Kalivas
Jun 10, 1998·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·P BienkowskiW Kostowski
Oct 26, 1999·Trends in Neurosciences·R Spanagel, F Weiss
Mar 25, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M R PicciottoV Zachariou
Jul 19, 2000·Pharmacology, Biochemistry, and Behavior·L A Parker, R V Mcdonald
Aug 23, 2001·Neuron·J A DaniF M Zhou
Aug 31, 2001·Pharmacology, Biochemistry, and Behavior·B A Hoshaw, M J Lewis
Oct 9, 2001·Nature Medicine·T J De VriesA N Schoffelmeer
Dec 26, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yossef Itzhak, Julio L Martin
Jan 30, 2002·British Journal of Pharmacology·Emmanuel ValjentRafael Maldonado
Mar 1, 2002·Pharmacological Reviews·Uri ShalevYavin Shaham
Apr 27, 2002·Science·Rachel I Wilson, Roger A Nicoll
May 23, 2002·Neuroscience Letters·Raffaella IsolaMaria Hadjiconstantinou
Jun 14, 2002·Pharmacology, Biochemistry, and Behavior·Amir H Rezvani, Edward D Levin

❮ Previous
Next ❯

Citations

Mar 31, 2010·Psychopharmacology·Catharine MontgomeryHarry R Sumnall
Oct 28, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Giovanni AddoloratoAntonello Bonci
Jan 31, 2009·Behavioural Pharmacology·Rodrigo M LeãoCleopatra S Planeta
May 24, 2011·Pharmacological Reports : PR·Barbara Budzyńska, Grażyna Biała
Jun 10, 2014·Pharmacological Reports : PR·Grażyna BiałaBarbara Budzyńska
Jul 30, 2011·Pharmacology & Therapeutics·Antonia Serrano, Loren H Parsons
Jun 15, 2011·Neuropharmacology·Nimish Sidhpura, Loren H Parsons
Sep 3, 2008·Brain Research Reviews·Maria A AguilarJose Miñarro
Sep 9, 2015·Psychopharmacology·Jonathan J CunninghamKaren Brebner
Jun 27, 2014·Pharmacology, Biochemistry, and Behavior·Deanne M BuffalariEric C Donny
May 20, 2020·Expert Opinion on Drug Discovery·Kevin Butler, Bernard Le Foll
Nov 17, 2017·Alcoholism, Clinical and Experimental Research·Marcus M WeeraJulia A Chester
Nov 24, 2020·Behavioural Brain Research·Rima Atria JaparinNorsyifa Harun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Related Papers

Progress in Neuro-psychopharmacology & Biological Psychiatry
D J Calcagnetti, M D Schechter
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Yossef Itzhak, Julio L Martin
© 2021 Meta ULC. All rights reserved